Stockholders' Deficit |
3 Months Ended |
|---|---|
Mar. 31, 2022 | |
| Stockholders' Equity Note [Abstract] | |
| Stockholders' Deficit |
Note 7 - Stockholders’ Deficit
Preferred Stock
As of March 31, 2022 and December 31, 2021, there were 50,000,000 authorized shares of the Company’s preferred stock, par value $0.0001.
Series A Preferred Sock
As of March 31, 2022 and December 31, 2021, the Company had 251 shares of its Series A preferred stock issued and outstanding.
Series B Preferred Stock
As of March 31, 2022 and December 31, 2021, the Company had 1,443 shares of its Series B preferred stock issued and outstanding.
Series C Preferred Stock
As of March 31, 2022 and December 31, 2021, the Company had 500,756 shares of its Series C preferred stock issued and outstanding.
Common Stock
Restricted Stock
During the three months ended March 31, 2022, the Company issued 33,332 shares of common stock in connection with vested restricted stock units. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|